Novel cell cytometry devices have recently emerged as crucial analytical and visualization tools that have revolutionized the global cell cytometry industry. These technologically driven tools are used for multiple purposes in the research industry, such as identification and analysis of cells in a biological sample, cell characterization, cell sorting, cell cycle analyses, cell proliferation assays, immunophenotyping and hematological studies.
Q1. What are the limitations of conventional cell cytometers?
The key concerns related to traditional cell cytometers include long turnover rates and poor visualization of analysis output. In addition, the conventional systems are incapable of handling large sample size and lack data processing software.
Q2. What are the different types of novel cell cytometers? What are the key advantages offered by novel cell cytometers?
In order to overcome the challenges of conventional cell cytometers, several medical device companies have developed technologically advanced variants of cell cytometers, including flow cytometers, facs flow cytometers, image cytometers, and time lapse cytometers. These novel devices offer various advantages; for instance, the high throughput flow cytometers have the ability to rapidly analyze large libraries of cells at once and allow the measurement of various characteristics of a sample. On the other hand, image cytometers are designed to visualize the cells and analyze multiple parameters of the sample using various proprietary features, such as spectral absorbance, multiple fluorescence channels, brightfield microscopy and luminescence at a greater speed.
Q3. What is the current market landscape of global high throughput flow cytometers and image cytometers market?
Presently, more than 180 high throughput flow / image cytometers that offer improved turnaround time and ease of operability are available in the market to streamline analytical workflows. It is worth highlighting that several novel cell cytometer developers have entered into strategic alliances in order to enhance their existing product capabilities and consolidate their presence in this domain. Additionally, close to 80% of the global events in this industry have been organized, since 2020. Several patents related to high throughput flow cytometers and image cytometers have been recently filed / granted, demonstrating the continuous innovation in this domain.
Q4. What are the key value drivers in the global cell cytometry market, focusing on high throughput flow cytometers and image cytometers?
In the recent years, the global cell cytometry market has witnessed an increase in the demand for advanced cell analyzers that are capable of not only counting / sorting the cells but also offer assessment of cell functions / characteristics in addition to the identification of potential biomarkers. Additionally, the adoption of high throughput flow cytometers and image cytometers in novel research application areas, including proteomics, cytogenomics and oncology research, has further contributed to the growth of this market.
Q5. What is the current / future market size of global cell cytometry market, focusing on high throughput flow cytometers and image cytometers? Which segments of this market are anticipated to capture the major share?
The global cell cytometry market, focusing on high through flow cytometers and image cytometers, is projected to grow at a CAGR of 8.6% in the coming years. Currently, in terms of type of cytometer, the market is captured by high throughput cell cytometers. However, this trend is expected to change in the foreseen future as the demand for image cytometers is anticipated to increase in the next 8 years. Specifically, in terms of geography, the market in North America is likely to grow at a relatively faster pace in the long term.
Q6. Who are the key players engaged in the global cell cytometry market, focusing on high through flow cytometers and image cytometers?
Examples of key players engaged in this domain (which have also been captured in this report) include Agilent, Beckton Dickinson, Beckman Coulter Life Sciences, Bio-Rad, Chemometec, Milkotronic, Nexcelom Bioscience, Sartorius, Sony Biotechnology, ThermoFisher Scientific and Union Biometrica.
Scope of the Report
The “Global Cell Cytometry Market, Focus on High Throughput Flow Cytometers and Image Cytometers by Type of Cytometer (High Throughput Flow Cytometers and Image Cytometers), Company Size (Very Small, Small, Mid-sized, Large and Very Large), and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035” report features an extensive study on the current market landscape and future potential of high throughput flow cytometers and image cytometers, over the next decade. The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. In addition to other elements, the report includes:
- A general overview of cell cytometry, featuring information on the different types of cytometry, namely high throughput flow cytometry and image cytometry, along with details on their advantages and limitations. Further, the chapter presents an array of Google trends analysis, highlighting the emerging focus areas, key historical trends, and geographical activity, offering insights on how this field has evolved over the last five years.
- A detailed assessment of the market landscape of high throughput flow cytometers based on several relevant parameters, such as type of high throughput flow cytometer, throughput rate (wells per minute), detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions (W×D×H), sample volume (in µl), type of detection mechanism(s), and application(s). In addition, the chapter includes analysis of high throughput flow cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products offered).
- An insightful product competitiveness analysis of high throughput flow cytometers, based on developer power (based on the experience of the developer in this industry), and product competitiveness (in terms of type of high throughput flow cytometer, throughput rate, detection rate, type of plate format, number of color channels, number of laser channels, number of detection channels, product dimensions, sample volume (in µl), type of detection mechanism(s) and application(s)).
- A detailed assessment of the market landscape of image cytometers based on several relevant parameters, such as type of image cytometer, processing time, type of plate format, output format, sample volume, product dimensions (W×D×H) and application(s). In addition, the chapter includes analysis of image cytometer developers, along with information on their year of establishment, company size, location of headquarters and leading players (in terms of number of products being offered).
- An insightful product competitiveness analysis of image cytometers, based on developer power (based on the experience of the developer in this industry), and product competitiveness (in terms of type of image cytometer, processing time, output format, average sample volume and application(s)).
- Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in the development / commercialization of cell cytometers (high throughput flow cytometers and image cytometers). Each profile features a brief overview of the company, recent developments and an informed future outlook.
- An insightful analysis of the partnerships that have been inked within the global cell cytometry industry since 2017, based on several relevant parameters, such as year of partnership, type of partnership (acquisitions, asset acquisitions, commercialization agreements, commercialization and distribution agreements, distribution agreements, product development agreements storage and distribution agreements and others), most active players (in terms of number of deals inked) and regional distribution of partnership activity.
- An analysis of various recent developments / trends related to global cell cytometry domain, offering insights on the funding activity in this domain, based on several relevant parameters, such as year of funding, type of funding, amount invested (USD Million), most active players (in terms of number of instances and amount raised), and most active investors (in terms of number of instances). In addition, it provides information on the analysis of the global events attended by the participants, based on several relevant parameters, such as year of event, event platform, type of event, most active organizers (in terms of number of events) and most active organizations (in terms of number of participants).
- An insightful analysis of the patents filed / granted for cell cytometry, since 2020, taking into consideration various relevant parameters, such as type of patent, publication year, annual number of granted patents and patent applications, geographical location, CPC symbols, emerging focus areas, type of organization, leading players (in terms of number of patents granted / filed) and patent characteristics. In addition, the chapter includes a detailed patent benchmarking and an insightful valuation analysis.
One of the key objectives of the report was to estimate the existing market size and the future opportunity for cell cytometry, over the coming 13 years. We have provided informed estimates on the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as type of cytometer (high throughput flow cytometers and image cytometers), company size (very small, small, mid-sized, large, and very large) and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the World). In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the anticipated industry’s growth. The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Frequently Asked Questions
- Which are the popular types of cytometers available in the market?
- Who are the leading players engaged in the development of high throughput flow cytometers and image cytometers?
- Which partnership models are commonly adopted by stakeholders engaged in this industry?
- What are the investment trends in the global cell cytometry industry?
- Who are the key investors that are actively engaged in supporting the development and commercialization of cell cytometers?
- What are the key agenda items being discussed in various global events / conferences that are related to cell cytometry?
- How has the patent landscape evolved in this industry?
- What will be the total market value of the global cell cytometry market in 2035?
- Which key geographical region of the global cell cytometry market is expected to witness the highest growth?
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3E Bioventures
- 5 Prime Ventures
- Abacus dx
- Accellix
- ACEA Biosciences (acquired by Agilent)
- Agilent
- Ampersand Capital Partners
- Anzu Partners
- Beckman Coulter Life Sciences (acquired by Danaher)
- Becton Dickinson
- BennuBio
- BioLegend (a subsidiary of PerkinElmer)
- bioMérieux
- Bionovation Biotech
- Bioscribe
- Bio-Rad Laboratories
- Casdin Capital
- Chemometec
- Cottonwood Technology Fund
- Co-Win Ventures
- Cyberfreight Pharma Logistics
- Cytek Biosciences
- Cytobank
- Cytognos (acquired by Becton Dickinson)
- De Novo Software
- Diethelm Keller Siber Hegner (DKSH)
- Easy Prosperity
- Eight Roads Ventures
- FlowJo
- F-Prime Capital
- FusionX Ventures
- GE Healthcare
- Hillhouse Capital
- Illumina Ventures
- IncellDx
- Luminex (acquired by DiaSorin)
- LYFE Capital
- Merck
- MilliporeSigma
- Milkotronic
- Miltenyi Biotec
- Molecular Devices (acquired by Maureen Data Systems)
- NanoCellect Biomedical
- National Institutes of Health
- Nexcelom Bioscience (a subsidiary of PerkinElmer)
- Northern Light Venture Capital
- OrbiMed
- PerkinElmer
- Phitonex (acquired by Thermo Fisher Scientific)
- Polaris Biology
- Premas Life Sciences
- RA Capital
- SAGIAN Equity
- Sartorius
- Sony Biotechnology
- Stratedigm
- Sun Mountain Capital
- Sysmex
- Thermo Fisher Scientific
- ThinkCyte
- Thorlabs
- Tramway Venture Partners
- Union Biometrica
- Vala Sciences
- Vertical Venture Partners
- Virginia Venture Partners (a subsidiary of VIPC)
- Warburg Pincus
- Yokogawa
- Yonjin Capital (also known as Yonjin Venture)
- Qiagen
Methodology
LOADING...